264 related articles for article (PubMed ID: 22460810)
1. DOG1: a novel marker of salivary acinar and intercalated duct differentiation.
Chênevert J; Duvvuri U; Chiosea S; Dacic S; Cieply K; Kim J; Shiwarski D; Seethala RR
Mod Pathol; 2012 Jul; 25(7):919-29. PubMed ID: 22460810
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of DOG-1 Expression in Salivary Gland Tumours and Comparison with Myoepithelial Markers.
Khurram SA; Speight PM
Head Neck Pathol; 2019 Jun; 13(2):140-148. PubMed ID: 29671211
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
Abd Raboh NM; Hakim SA
Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
[TBL] [Abstract][Full Text] [Related]
4. Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands.
Mariano FV; Gómez CA; de Souza do Nascimento J; Dos Santos HT; Egal ES; Montalli VA; Vargas PA; de Almeida OP; Altemani A
Head Neck Pathol; 2016 Dec; 10(4):429-436. PubMed ID: 27177644
[TBL] [Abstract][Full Text] [Related]
5. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-6 is a marker of serous acinar cell differentiation in normal and neoplastic human salivary gland.
Heikinheimo KA; Laine MA; Ritvos OV; Voutilainen RJ; Hogan BL; Leivo IV
Cancer Res; 1999 Nov; 59(22):5815-21. PubMed ID: 10582704
[TBL] [Abstract][Full Text] [Related]
7. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.
Ohtomo R; Mori T; Shibata S; Tsuta K; Maeshima AM; Akazawa C; Watabe Y; Honda K; Yamada T; Yoshimoto S; Asai M; Okano H; Kanai Y; Tsuda H
Mod Pathol; 2013 Aug; 26(8):1041-50. PubMed ID: 23558573
[TBL] [Abstract][Full Text] [Related]
8. [Expression of NR4A3/NOR-1 in acinic cell carcinoma of the salivary gland].
Cheng K; Wang X; Wei X; Ma J; Xia QY; Shi QL; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1142-1146. PubMed ID: 33152819
[No Abstract] [Full Text] [Related]
9. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
[TBL] [Abstract][Full Text] [Related]
10. Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.
Pinto A; Nosé V; Rojas C; Fan YS; Gomez-Fernandez C
Mod Pathol; 2014 Jan; 27(1):30-7. PubMed ID: 23807775
[TBL] [Abstract][Full Text] [Related]
11. Expression of the adenocarcinoma-related antigen recognized by monoclonal antibody 44-3A6 in salivary gland neoplasias.
Bentz BG; Haines GK; vonSchlegell AS; Elseth KM; Hanson DG; Radosevich JA
Otolaryngol Head Neck Surg; 1998 May; 118(5):603-9. PubMed ID: 9591857
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland.
Hsieh MS; Jeng YM; Jhuang YL; Chou YH; Lin CY
Histopathology; 2016 Apr; 68(5):641-7. PubMed ID: 26212680
[TBL] [Abstract][Full Text] [Related]
13. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.
Stevens TM; Kovalovsky AO; Velosa C; Shi Q; Dai Q; Owen RP; Bell WC; Wei S; Althof PA; Sanmann JN; Sweeny L; Carroll WR; Siegal GP; Bullock MJ; Brandwein-Gensler M
Mod Pathol; 2015 Aug; 28(8):1084-100. PubMed ID: 26089091
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma.
Skaugen JM; Seethala RR; Chiosea SI; Landau MS
Cancer Cytopathol; 2021 Feb; 129(2):104-113. PubMed ID: 32809265
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
Hung YP; Jo VY; Hornick JL
Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
[TBL] [Abstract][Full Text] [Related]
16. Expression of SOX10 in Salivary Gland Oncocytic Neoplasms: A Review and a Comparative Analysis with Other Immunohistochemical Markers.
Schmitt AC; Cohen C; Siddiqui MT
Acta Cytol; 2015; 59(5):384-90. PubMed ID: 26619208
[TBL] [Abstract][Full Text] [Related]
17. DOG1 as an Immunohistochemical Marker of Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis.
Fiorentino V; Straccia P; Tralongo P; Musarra T; Pierconti F; Martini M; Fadda G; Rossi ED; Larocca LM
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077107
[TBL] [Abstract][Full Text] [Related]
18. Most nonparotid "acinic cell carcinomas" represent mammary analog secretory carcinomas.
Bishop JA; Yonescu R; Batista D; Eisele DW; Westra WH
Am J Surg Pathol; 2013 Jul; 37(7):1053-7. PubMed ID: 23681074
[TBL] [Abstract][Full Text] [Related]
19. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
[TBL] [Abstract][Full Text] [Related]
20. Combined DOG1 and Mammaglobin Immunohistochemistry Is Comparable to ETV6-breakapart Analysis for Differentiating Between Papillary Cystic Variants of Acinic Cell Carcinoma and Mammary Analogue Secretory Carcinoma.
Said-Al-Naief N; Carlos R; Vance GH; Miller C; Edwards PC
Int J Surg Pathol; 2017 Apr; 25(2):127-140. PubMed ID: 27670353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
